FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

708097004: Immunohistochemistry technique (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3033004017 Immunohistochemistry en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3034678011 Immunohistochemistry technique en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3034685010 Immunohistochemistry technique (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Immunohistochemistry Is a Technique true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of breast by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Status of estrogen receptor stain in control cells by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Status of progesterone receptor stain in control cells by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cells with progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cells with estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Intensity of stain of oestrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Observation using immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Intensity of stain of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of breast by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of colon by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of colon by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of ALK tyrosine kinase receptor in primary malignant neoplasm of lung by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of proto-oncogene tyrosine-protein kinase ROS in primary malignant neoplasm of lung by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of estrogen receptor in primary malignant neoplasm of endometrium by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of endometrium by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of appendix by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of progesterone receptor in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of adrenal gland by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of small intestine by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of colon by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of colon by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of stomach by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of programmed cell death 1 ligand 1 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of lung by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of pancreas by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of anoctamin-1 in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of mast/stem cell growth factor receptor Kit in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Presence of succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of colon by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of thyroid by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Intensity of stain of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Intensity of stain of oestrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of anoctamin-1 in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of colon by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of colon by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of ALK tyrosine kinase receptor in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of colon by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of mast/stem cell growth factor receptor Kit in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of estrogen receptor in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of colon by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of proto-oncogene tyrosine-protein kinase ROS in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of endometrium by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of progesterone receptor in primary malignant neoplasm of endometrium by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of programmed cell death 1 ligand 1 in primary malignant neoplasm of lung by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of lung by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Presence of succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cells with estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cells with progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of breast by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of appendix by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of adrenal gland by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of small intestine by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of stomach by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of pancreas by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of colon by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of thyroid by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of cecum and/or colon and/or rectum by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Human epidermal growth factor receptor 2 immunohistochemistry score (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for chromogranin antigen in primary malignant neoplasm by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for synaptophysin antigen in primary malignant neoplasm by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Status of detection of DNA mismatch repair protein in malignant neoplasm using immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for antigen MIB-1 in primary malignant neoplasm by immunohistochemistry Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) Technique False Immunohistochemistry Inferred relationship Some 2
Percent of cell nuclei positive for chromogranin antigen in primary malignant neoplasm by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for synaptophysin antigen in primary malignant neoplasm by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Status of detection of DNA mismatch repair protein in malignant neoplasm using immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for antigen MIB-1 in primary malignant neoplasm by immunohistochemistry Technique True Immunohistochemistry Inferred relationship Some 1
Percent of cell nuclei positive for antigen p16 in primary malignant neoplasm by immunohistochemistry (observable entity) Technique True Immunohistochemistry Inferred relationship Some 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start